O21: Medical problems in fragile X syndrome: FORWARD results from over 1400 participants age 0-21 with an FMR-1 full mutation* by Nicole Tartaglia, Randi Hagerman, Elizabeth Berry-Kravis

Get full text

Digital gait markers to potentially distinguish fragile X-associated tremor/ataxia syndrome, Parkinson’s disease, and essential tremor by Erin E. Robertson-Dick, Emily C. Timm, Gian Pal, Bichun Ouyang, Yuanqing Liu, Elizabeth Berry-Kravis, Elizabeth Berry-Kravis, Elizabeth Berry-Kravis, Deborah A. Hall, Joan A. O’Keefe, Joan A. O’Keefe

Get full text

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome by Elizabeth Berry-Kravis, Allison Sumis, Crystal Hervey, Shaguna Mathur

Get full text

Proteomics insights into fragile X syndrome: Unraveling molecular mechanisms and therapeutic avenues by Diana A. Abbasi, Elizabeth Berry-Kravis, Xinyu Zhao, Stephanie M. Cologna

Get full text

Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome by Debra L. Reisinger, Rebecca C. Shaffer, Nicole Tartaglia, Elizabeth Berry-Kravis, Craig A. Erickson

Get full text

Mortality in Women across the <i>FMR1</i> CGG Repeat Range: The Neuroprotective Effect of Higher Education by Jinkuk Hong, Robert S. Dembo, Leann Smith DaWalt, Mei Wang Baker, Elizabeth Berry-Kravis, Marsha R. Mailick

Get full text

Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment by Anne Hoffmann, Angel Wang, Natalie Berger, Lisa Cordeiro, Rebecca Shaffer, Nicole Tartaglia, Craig Erickson, Elizabeth Berry-Kravis

Get full text

Potential Prodromal Digital Postural Sway Markers for Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Detected via Dual-Tasking and Sensory Manipulation by Emily C. Timm, Nicollette L. Purcell, Bichun Ouyang, Elizabeth Berry-Kravis, Deborah A. Hall, Joan Ann O’Keefe

Get full text

Developmental associations between cognition and adaptive behavior in intellectual and developmental disability by Andrew Dakopolos, Emma Condy, Elizabeth Smith, Danielle Harvey, Aaron J. Kaat, Jeanine Coleman, Karen Riley, Elizabeth Berry-Kravis, David Hessl

Get full text

Abnormal neural sensitivity to rewards as a candidate process of high depression risk in the FMR1 premutation: A pilot study by Roslyn Harold, Bridgette Kelleher, Keisha Novak, Wei Siong Neo, Teagan Stump, Taylor Lee, Tessa Garwood, Elizabeth Berry-Kravis, Dan Foti

Get full text

The association between expressive language skills and adaptive behavior in individuals with Down syndrome by Laura del Hoyo Soriano, Jennifer Catalina Villarreal, Audra Sterling, Jamie Edgin, Elizabeth Berry-Kravis, Debra R. Hamilton, Angela John Thurman, Leonard Abbeduto

Get full text

Analysis of a Repetitive Language Coding System: Comparisons between Fragile X Syndrome, Autism, and Down Syndrome by Anne Hoffmann, Angela John Thurman, Audra Sterling, Sara T. Kover, Lizbeth Finestack, Elizabeth Berry-Kravis, Jamie O. Edgin, Andrea Drayton, Eric Fombonne, Leonard Abbeduto

Get full text

Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome by Marika C. Coffman, Rebecca C. Shaffer, Lauren M. Schmitt, Kelli C. Dominick, Ernest Pedapati, Angel Wang, Elizabeth Berry-Kravis, Nicole Tartaglia, Craig A. Erickson

Get full text

Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype. by Stephen C Collins, Brad Coffee, Paul J Benke, Elizabeth Berry-Kravis, Fred Gilbert, Ben Oostra, Dicky Halley, Michael E Zwick, David J Cutler, Stephen T Warren

Get full text

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis by Skylar Luu, Haley Province, Elizabeth Berry-Kravis, Randi Hagerman, David Hessl, Dhananjay Vaidya, Reymundo Lozano, Hilary Rosselot, Craig Erickson, Walter E. Kaufmann, Dejan B. Budimirovic

Get full text

Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegeneration by Aleksandar Videnovic, Helle C. V. Pfeiffer, Helle C. V. Pfeiffer, Anna Tylki-Szymańska, Elizabeth Berry-Kravis, Fatih Ezgü, Jitendra Ganju, Agnieszka Jurecka, Anthony E. Lang

Get full text

Symptoms of Autism Spectrum Disorder in Individuals with Down Syndrome by Amanda Dimachkie Nunnally, Vivian Nguyen, Claudine Anglo, Audra Sterling, Jamie Edgin, Stephanie Sherman, Elizabeth Berry-Kravis, Laura del Hoyo Soriano, Leonard Abbeduto, Angela John Thurman

Get full text

Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1 by Sonali Mishra, Pamela Kell, David Scherrer, Dennis J. Dietzen, Charles H. Vite, Elizabeth Berry-Kravis, Cristin Davidson, Stephanie M. Cologna, Forbes D. Porter, Daniel S. Ory, Xuntian Jiang

Get full text

Expressive language sampling and outcome measures for treatment trials in fragile X and down syndromes: composite scores and psychometric properties by Leonard Abbeduto, Laura del Hoyo Soriano, Elizabeth Berry-Kravis, Audra Sterling, Jamie O. Edgin, Nadia Abdelnur, Andrea Drayton, Anne Hoffmann, Debra Hamilton, Danielle J. Harvey, Angela John Thurman

Get full text

A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome by Kathleen Campbell, Jeffrey L. Neul, David N. Lieberman, Elizabeth Berry-Kravis, Tim A. Benke, Cary Fu, Alan Percy, Bernhard Suter, David Morris, Randall L. Carpenter, Eric D. Marsh, Jana von Hehn

Get full text